OCHT Orchestra Therapeutics, Inc. featured news, full reports, and detailed charts
Orchestra Therapeutics, Inc. (OCHT/OCHT.PK) Wrap Up:
Orchestra Therapeutics, Inc., an immuno-pharmaceutical company, focuses on the development of various products to treat autoimmune and infectious diseases. It offers NeuroVax, an immune-based therapeutic product, which is based on T-cell receptor peptide technology for the treatment of multiple sclerosis. NeuroVax is in Phase II clinical trails. The company, formerly known as The Immune Response Corporation, was founded in 1986 and changed its name to Orchestra Therapeutics, Inc. in April 2007. Orchestra Therapeutics, Inc. is headquartered in Carlsbad, California. On October 13, 2008, Orchestra Therapeutics, Inc. filed a voluntary petition for liquidation under Chapter 7 in the US Bankruptcy...www.orchestratherapeutics.com
39 Employees
Founded in 1986
Orchestra Therapeutics, Inc. (OCHT:OTC)
OCHT Top Compensated Officers
No compensation data is available at this time for the top officers at this company.
Executives, Board Directors
OCHT Competitors
| Company | Last | Change | |
| No competitor information is available for OCHT. | |||
| Market data is delayed at least 20 minutes. | |||
Industry Analysis
| Valuation | OCHT | Industry Range |
| No financial data is available for OCHT. | ||
|
OCHT transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
More Recent News About Orchestra Therapeutics, Inc.
More news for OCHT
ORCHESTRA THERAPEUTICS, INC. Financials
PERIOD ENDING30-Jun-0731-Mar-0731-Dec-0630-Sep-06Total Revenue4 4 904 6 Cost of Revenue - - - - Gross Profit4 4 904 6 Operating ExpensesResearch Development1,834 2,269 2,501 2,551 Selling General and Administrative1,078 1,473 2,371 1,415 Non Recurring - - - - Others - - - - Total Operating Expenses - - - - Operating Income or Loss(2,908)(3,738)(3,968)(3,960)Income from Continuing OperationsTotal Other Income/Expenses Net1,872 2,951 2,191 4,701 Earnings Before Interest And Taxes(1,036)(787)(1,777)741 Interest Expense1,030 1,130 1,318 1,929 Income Before Tax(2,066)(1,917)(3,095)(1,188)Income Tax Expense - - - - Minority Interest - - - - Net Income From Continuing Ops(2,066)(1,917)(3,095)(1,188)Non-recurring EventsDiscontinued Operations - - - - Extraordinary Items - - - - Effect Of Accounting Changes - - - - ...Click here to read the whole Article (external link)
Would you like to leave a comment about Orchestra Therapeutics, Inc. OCHT/OCHT.PK
Find out what social network information about Orchestra Therapeutics, Inc. are available on RealpenniesWorst 5 - Click here to find out what stocks have been voted down by our visitors and users
Besides Orchestra Therapeutics, Inc. there is more great information available at Realpennies.com